These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 22462637)
1. A mutation at IVS1 + 5 of the von Hippel-Lindau gene resulting in intron retention in transcripts is not pathogenic in a patient with a tongue cancer?: case report. Asakawa T; Esumi M; Endo S; Kida A; Ikeda M BMC Med Genet; 2012 Mar; 13():23. PubMed ID: 22462637 [TBL] [Abstract][Full Text] [Related]
2. Tongue cancer patients have a high frequency of allelic loss at the von Hippel-Lindau gene and other loci on 3p. Asakawa T; Esumi M; Endo S; Kida A; Ikeda M Cancer; 2008 Feb; 112(3):527-34. PubMed ID: 18072267 [TBL] [Abstract][Full Text] [Related]
3. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression. Jensen RL; Gillespie D; House P; Layfield L; Shelton C J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285 [TBL] [Abstract][Full Text] [Related]
4. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors. Prowse AH; Webster AR; Richards FM; Richard S; Olschwang S; Resche F; Affara NA; Maher ER Am J Hum Genet; 1997 Apr; 60(4):765-71. PubMed ID: 9106522 [TBL] [Abstract][Full Text] [Related]
5. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing. Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822 [TBL] [Abstract][Full Text] [Related]
6. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531 [TBL] [Abstract][Full Text] [Related]
7. VHL Germline Mutations in Argentinian Patients with Clinical Diagnoses or Single Typical Manifestations of Type 1 von Hippel-Lindau Disease. Mathó C; Sansó G; Diez B; Barontini M; Pennisi PA Genet Test Mol Biomarkers; 2016 Dec; 20(12):771-776. PubMed ID: 27617348 [TBL] [Abstract][Full Text] [Related]
8. Germline mutations in the von Hippel-Lindau gene in Italian patients. Ciotti P; Garuti A; Gulli R; Ballestrero A; Bellone E; Mandich P Eur J Med Genet; 2009; 52(5):311-4. PubMed ID: 19464396 [TBL] [Abstract][Full Text] [Related]
9. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma. Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900 [TBL] [Abstract][Full Text] [Related]
10. Intronic mutation of the VHL gene associated with central nervous system hemangioblastomas in two Chinese families with Von Hippel-Lindau disease: case report. Liu Z; Zhou J; Li L; Yi Z; Lu R; Li C; Gong K BMC Med Genet; 2020 Oct; 21(1):191. PubMed ID: 33004005 [TBL] [Abstract][Full Text] [Related]
11. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene. Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223 [TBL] [Abstract][Full Text] [Related]
12. Identification of somatic mutations in the von Hippel-Lindau (VHL) gene in a patient with renal cell carcinoma. Wang WC; Chen HJ; Tseng YH; Lai YC J Formos Med Assoc; 2009 Nov; 108(11):886-93. PubMed ID: 19933033 [TBL] [Abstract][Full Text] [Related]
13. Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease. Faiyaz-Ul-Haque M; Jamil M; Aslam M; Abalkhail H; Al-Dayel F; Basit S; Nawaz Z; Zaidi SHE Cancer Genet; 2020 May; 243():1-6. PubMed ID: 32179488 [TBL] [Abstract][Full Text] [Related]
14. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma. Olschwang S; Richard S; Boisson C; Giraud S; Laurent-Puig P; Resche F; Thomas G Hum Mutat; 1998; 12(6):424-30. PubMed ID: 9829912 [TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation. Gomy I; Molfetta GA; de Andrade Barreto E; Ferreira CA; Zanette DL; Casali-da-Rocha JC; Silva WA Fam Cancer; 2010 Dec; 9(4):635-42. PubMed ID: 20567917 [TBL] [Abstract][Full Text] [Related]
16. Three novel germ-line VHL mutations in Hungarian von Hippel-Lindau patients, including a nonsense mutation in a fifteen-year-old boy with renal cell carcinoma. Losonczy G; Fazakas F; Pfliegler G; Komáromi I; Balázs E; Pénzes K; Berta A BMC Med Genet; 2013 Jan; 14():3. PubMed ID: 23298237 [TBL] [Abstract][Full Text] [Related]
17. Von Hippel-Lindau syndrome. A pleomorphic condition. Friedrich CA Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173 [TBL] [Abstract][Full Text] [Related]
18. A deletion mutation of the VHL gene associated with a patient with sporadic von Hippel-Lindau disease. Jia D; Tang B; Shi Y; Wang J; Sun Z; Chen Z; Zhang L; Xia K; Jiang H J Clin Neurosci; 2013 Jun; 20(6):842-7. PubMed ID: 23632291 [TBL] [Abstract][Full Text] [Related]
19. Novel gene mutation in von Hippel-Lindau disease - a report of two cases. Wang J; Cao W; Wang Z; Zhu H BMC Med Genet; 2019 Dec; 20(1):194. PubMed ID: 31823746 [TBL] [Abstract][Full Text] [Related]
20. De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease. Ding X; Zhang C; Frerich JM; Germanwala A; Yang C; Lonser RR; Mao Y; Zhuang Z; Zhang M J Neurosurg; 2014 Aug; 121(2):384-386. PubMed ID: 24678776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]